Behavioral practices regarding combination therapies for HIV/AIDS

Marya Gwadz, Roberto De Vogli, Mary Jane Rotheram-Borus, Marie M. Diaz, Tri Cisek, Nionne B. James, Nim Tottenham

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We assessed knowledge and utilization of, and adherence to, combination antiretroviral therapies including protease inhibitors among 210 low-income persons living with HIV/AIDS (aged 18 to 52 years, M = 32.5 years; 43% Latino, 34% African American). Most (65%) had received protease inhibitors at some point, although only 54% had received them in the previous 3 months. Parents with AIDS were more likely to have taken protease inhibitors than young adults (72% vs. 33%). About half of those taking combination antiretroviral therapies reported consistent adherence (55%), even among the 64% who experienced side effects. However, the reliability of these reports appears moderate. More than half of those taking combination therapies reported improvements in their health (62%). Almost all participants reported having their viral loads tested (87%), on average 3.7 times (SD = 3.6 times). More than one third (38%) reported undetectable viral loads. Participants were moderately informed about protease inhibitors (64% of answers correct in a knowledge questionnaire). Using multivariate logistic regression, we found that those who abstained from substance use were more likely to be adherent (odds ratio = 4.75; 95% CI = 1.63 - 13.85). Adherence was not related to sexual behavior. These reports suggest that persons with AIDS are at risk for developing treatment-resistant strains of HIV because half or fewer have adequate levels of adherence, and further, a substantial minority are not on approved combination therapies. Interventions to help persons living with AIDS adhere to complex medication regimens are needed, particularly for those who use substances, as well as to assist young adults with overcoming barriers to receiving combination therapies.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalJournal of Sex Education and Therapy
Volume24
Issue number1-2
StatePublished - 1999
Externally publishedYes

Fingerprint

Acquired Immunodeficiency Syndrome
HIV
Protease Inhibitors
Viral Load
Young Adult
Therapeutics
Hispanic Americans
Sexual Behavior
African Americans
Parents
Logistic Models
Odds Ratio
Health

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Gwadz, M., De Vogli, R., Rotheram-Borus, M. J., Diaz, M. M., Cisek, T., James, N. B., & Tottenham, N. (1999). Behavioral practices regarding combination therapies for HIV/AIDS. Journal of Sex Education and Therapy, 24(1-2), 81-88.

Behavioral practices regarding combination therapies for HIV/AIDS. / Gwadz, Marya; De Vogli, Roberto; Rotheram-Borus, Mary Jane; Diaz, Marie M.; Cisek, Tri; James, Nionne B.; Tottenham, Nim.

In: Journal of Sex Education and Therapy, Vol. 24, No. 1-2, 1999, p. 81-88.

Research output: Contribution to journalArticle

Gwadz, M, De Vogli, R, Rotheram-Borus, MJ, Diaz, MM, Cisek, T, James, NB & Tottenham, N 1999, 'Behavioral practices regarding combination therapies for HIV/AIDS', Journal of Sex Education and Therapy, vol. 24, no. 1-2, pp. 81-88.
Gwadz M, De Vogli R, Rotheram-Borus MJ, Diaz MM, Cisek T, James NB et al. Behavioral practices regarding combination therapies for HIV/AIDS. Journal of Sex Education and Therapy. 1999;24(1-2):81-88.
Gwadz, Marya ; De Vogli, Roberto ; Rotheram-Borus, Mary Jane ; Diaz, Marie M. ; Cisek, Tri ; James, Nionne B. ; Tottenham, Nim. / Behavioral practices regarding combination therapies for HIV/AIDS. In: Journal of Sex Education and Therapy. 1999 ; Vol. 24, No. 1-2. pp. 81-88.
@article{70df99818df644288c2ef0fd77bb53e9,
title = "Behavioral practices regarding combination therapies for HIV/AIDS",
abstract = "We assessed knowledge and utilization of, and adherence to, combination antiretroviral therapies including protease inhibitors among 210 low-income persons living with HIV/AIDS (aged 18 to 52 years, M = 32.5 years; 43{\%} Latino, 34{\%} African American). Most (65{\%}) had received protease inhibitors at some point, although only 54{\%} had received them in the previous 3 months. Parents with AIDS were more likely to have taken protease inhibitors than young adults (72{\%} vs. 33{\%}). About half of those taking combination antiretroviral therapies reported consistent adherence (55{\%}), even among the 64{\%} who experienced side effects. However, the reliability of these reports appears moderate. More than half of those taking combination therapies reported improvements in their health (62{\%}). Almost all participants reported having their viral loads tested (87{\%}), on average 3.7 times (SD = 3.6 times). More than one third (38{\%}) reported undetectable viral loads. Participants were moderately informed about protease inhibitors (64{\%} of answers correct in a knowledge questionnaire). Using multivariate logistic regression, we found that those who abstained from substance use were more likely to be adherent (odds ratio = 4.75; 95{\%} CI = 1.63 - 13.85). Adherence was not related to sexual behavior. These reports suggest that persons with AIDS are at risk for developing treatment-resistant strains of HIV because half or fewer have adequate levels of adherence, and further, a substantial minority are not on approved combination therapies. Interventions to help persons living with AIDS adhere to complex medication regimens are needed, particularly for those who use substances, as well as to assist young adults with overcoming barriers to receiving combination therapies.",
author = "Marya Gwadz and {De Vogli}, Roberto and Rotheram-Borus, {Mary Jane} and Diaz, {Marie M.} and Tri Cisek and James, {Nionne B.} and Nim Tottenham",
year = "1999",
language = "English (US)",
volume = "24",
pages = "81--88",
journal = "Journal of Sex Education and Therapy",
issn = "0161-4576",
publisher = "Guilford Publications",
number = "1-2",

}

TY - JOUR

T1 - Behavioral practices regarding combination therapies for HIV/AIDS

AU - Gwadz, Marya

AU - De Vogli, Roberto

AU - Rotheram-Borus, Mary Jane

AU - Diaz, Marie M.

AU - Cisek, Tri

AU - James, Nionne B.

AU - Tottenham, Nim

PY - 1999

Y1 - 1999

N2 - We assessed knowledge and utilization of, and adherence to, combination antiretroviral therapies including protease inhibitors among 210 low-income persons living with HIV/AIDS (aged 18 to 52 years, M = 32.5 years; 43% Latino, 34% African American). Most (65%) had received protease inhibitors at some point, although only 54% had received them in the previous 3 months. Parents with AIDS were more likely to have taken protease inhibitors than young adults (72% vs. 33%). About half of those taking combination antiretroviral therapies reported consistent adherence (55%), even among the 64% who experienced side effects. However, the reliability of these reports appears moderate. More than half of those taking combination therapies reported improvements in their health (62%). Almost all participants reported having their viral loads tested (87%), on average 3.7 times (SD = 3.6 times). More than one third (38%) reported undetectable viral loads. Participants were moderately informed about protease inhibitors (64% of answers correct in a knowledge questionnaire). Using multivariate logistic regression, we found that those who abstained from substance use were more likely to be adherent (odds ratio = 4.75; 95% CI = 1.63 - 13.85). Adherence was not related to sexual behavior. These reports suggest that persons with AIDS are at risk for developing treatment-resistant strains of HIV because half or fewer have adequate levels of adherence, and further, a substantial minority are not on approved combination therapies. Interventions to help persons living with AIDS adhere to complex medication regimens are needed, particularly for those who use substances, as well as to assist young adults with overcoming barriers to receiving combination therapies.

AB - We assessed knowledge and utilization of, and adherence to, combination antiretroviral therapies including protease inhibitors among 210 low-income persons living with HIV/AIDS (aged 18 to 52 years, M = 32.5 years; 43% Latino, 34% African American). Most (65%) had received protease inhibitors at some point, although only 54% had received them in the previous 3 months. Parents with AIDS were more likely to have taken protease inhibitors than young adults (72% vs. 33%). About half of those taking combination antiretroviral therapies reported consistent adherence (55%), even among the 64% who experienced side effects. However, the reliability of these reports appears moderate. More than half of those taking combination therapies reported improvements in their health (62%). Almost all participants reported having their viral loads tested (87%), on average 3.7 times (SD = 3.6 times). More than one third (38%) reported undetectable viral loads. Participants were moderately informed about protease inhibitors (64% of answers correct in a knowledge questionnaire). Using multivariate logistic regression, we found that those who abstained from substance use were more likely to be adherent (odds ratio = 4.75; 95% CI = 1.63 - 13.85). Adherence was not related to sexual behavior. These reports suggest that persons with AIDS are at risk for developing treatment-resistant strains of HIV because half or fewer have adequate levels of adherence, and further, a substantial minority are not on approved combination therapies. Interventions to help persons living with AIDS adhere to complex medication regimens are needed, particularly for those who use substances, as well as to assist young adults with overcoming barriers to receiving combination therapies.

UR - http://www.scopus.com/inward/record.url?scp=0032874657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032874657&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032874657

VL - 24

SP - 81

EP - 88

JO - Journal of Sex Education and Therapy

JF - Journal of Sex Education and Therapy

SN - 0161-4576

IS - 1-2

ER -